World2 outlets covering this

Pro Medicus FY26 slides: 28% revenue growth, A$407M in new contracts

First publishedAug 18, 02:38 UTC
Last updatedAug 18, 12:05 UTC · 8m ago
22 outletsInvesting.com · Company News
2 outlets over time — hover a bar for its window & outletslast updated
● Story signals

How strong is this topic?

5.7/10Significanceimpact & urgency
5.0/10Source trustoutlet authority
2Outletsindependent sources

Significance weighs impact, urgency & coverage breadth · Source trust is the outlets' average authority · more outlets means a more confirmed story.

Answer

Pro Medicus (ASX:PME) unveiled record financial results for fiscal year 2026 in its presentation dated August 18, 2026, showcasing robust growth across all key metrics despite currency headwinds. The medical imaging software company reported underlying revenue growth of 28% in constant currency terms, with EBIT margins expanding to 74.9%.

Reported by 2 outlets Investing.com · Company News. See all sources ↓

Pro Medicus (ASX:PME) unveiled record financial results for fiscal year 2026 in its presentation dated August 18, 2026, showcasing robust growth across all key metrics despite currency headwinds. The medical imaging software company reported underlying revenue growth of 28% in constant currency terms, with EBIT margins expanding to 74.9%. The market responded enthusiastically, with shares surging 13.02% to A$198.76, building on a 12.4% pre-market jump following the initial release. The Melbourne-based company, which provides enterprise imaging and radiology information systems through its Visage 7 platform, continues to demonstrate exceptional operating leverage and market penetration in North America, where it now serves more than half of the top 20 U.S.

Read the full report at Investing.com · Company News

Why it matters

2 outlets are covering this world story — one to watch as reporting develops.

In brief
What's the story?
Pro Medicus (ASX:PME) unveiled record financial results for fiscal year 2026 in its presentation dated August 18, 2026, showcasing robust growth across all key metrics despite currency headwinds. The medical imaging software company reported underlying revenue growth of 28% in constant currency terms, with EBIT margins expanding to 74.9%.
How widely is it covered?
2 outlets, average source rating 5.0/10.
When was it last updated?
8m ago.
Different angles across outlets
Coverage map

How outlets are framing the same story

Here's how each outlet is covering the story — compare their headlines and timing at a glance.

  • Coverage card1 outlet
    1Coverage
    Scouting report

    Pro Medicus FY26 slides: record growth, margins near 75%

    Sources1
    TypeCoverage
    Investing.com · Company News
Related in the knowledge graph
Sources (2)
Avg source rating 5.0/10
Processing cluster
A1A2A3B1B2B3
Share this article
Summarize with AI (opens AI chat with article URL · Gemini: prompt copied to clipboard)